Skip to content
Open access

Bifidobacterium longum Subspecies infantis M63 Enhances the Colitis-Alleviating Effect of 2′-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism

Sep 2026 · Foods · Vol 15, pp. 3113 · 0 citations · 37 references
Medicine

TL;DR

These findings demonstrate strain-dependent protective effects of 2′-FL + M63 showing the greatest overall efficacy in restoring intestinal barrier function and microbial metabolism, supporting its development as a candidate functional synbiotic food formulation.

Abstract

Both 2′-fucosyllactose (2′-FL) and Bifidobacterium can modulate gut health; however, whether their combination provides strain-dependent protection against colitis remains unclear. This study aimed to compare the protective effects of 2′-FL alone and in combination with Bifidobacterium longum subsp. infantis M63 or Bifidobacterium breve M16V in dextran sulfate sodium (DSS)-induced colitis. Forty-eight male C57BL/6J mice were randomly assigned to six groups: negative control, DSS model control, 5-aminosalicylic acid positive control, 2′-FL, 2′-FL + M63, and 2′-FL + M16V. The interventions were administered for two weeks, with 2.5% DSS supplied in the drinking water during the second week. Colitis-related indices, colonic histopathology, inflammatory cytokines, oxidative-stress markers, intestinal barrier-associated gene expression, gut microbiota composition, lactate, and short-chain fatty acids (SCFAs) were evaluated. Compared with the model control, 2′-FL and both synbiotic combinations ameliorated colonic tissue injury and goblet-cell loss. Both combinations significantly reduced IL-1β, whereas 2′-FL and both combinations reduced IL-6 and TNF-α. The combinations also increased catalase and glutathione peroxidase activities and decreased malondialdehyde levels. 2′-FL alone increased Occludin and RELMβ expression, whereas 2′-FL + M63 showed the strongest effects on tight-junction and mucus-barrier restoration, including increased Claudin-1, Claudin-2, ZO-1, TFF3, and MUC2 expression. All 2′-FL-containing interventions increased microbial diversity, while 2′-FL + M63 increased Bacteroidota, reduced Proteobacteria, and enriched Muribaculaceae and Ruminococcaceae. Both synbiotic combinations increased lactate and all measured SCFAs; 2′-FL + M63 produced the highest acetate level, whereas 2′-FL + M16V produced the highest propionate level, and both combinations markedly increased butyrate. These findings demonstrate strain-dependent protective effects, with 2′-FL + M63 showing the greatest overall efficacy in restoring intestinal barrier function and microbial metabolism, supporting its development as a candidate functional synbiotic food formulation.

Read PDF

Similar papers

Open access Sep 2026

Bifidobacterium animalis subsp. lactis V9 overcomes CYFRA 21-1–linked immunochemotherapy resistance in NSCLC via microbial metabolites

Gut dysbiosis drives therapeutic resistance, yet the relationships among typical tumor markers, gut microbiota, and treatment efficacy remain poorly defined. Here, elevated serum CYFRA 21-1 in advanced non–small cell lung cancer (NSCLC) correlates with gut dysbiosis, including Bifidobacterium animalis depletion and red...

Cui-Jiao Feng, Guang-Qi Gao, Qiuwen He et al. · 0 citations
Sep 2026

Strain-dependent effects of Bifidobacterium on loperamide-induced constipation via gut microbiota and abfA cluster.

BACKGROUND Constipation is a common gastrointestinal disorder. Although conventional treatments can alleviate symptoms, they often cause side effects. Bifidobacterium, a safe and well-tolerated probiotic, has demonstrated potential in constipation management; however, functional variability among strains limits its bro...

Xiao-Yan Song, Zi-Yuan Wang, Zi-Hao Zhang et al. · 0 citations
Aug 2026

Lactobacillus acidophilus LA15 plus Bifidobacterium animalis subsp. lactis Bi66 mitigates cyclophosphamide-induced immunosuppression in association with gut-immune axis modulation and AhR signaling recovery.

Compound AB probiotics alleviate CTX-induced immunosuppression in mice, and this effect correlates with restored gut microecology, enhanced SCFA metabolism, repaired intestinal barrier, and activated AhR signaling, providing evidence for developing probiotic preparations as adjuvant interventions against chemotherapy-r...

Mengyu Hou, Qian Cheng, Zheng-Rong Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.